Wimm-Bill-Dann Foods OJSC [NYSE: WBD] today announced its financial results for the full year and the fourth quarter ended December 31, 2009.

Highlights for the full year and the fourth quarter of 2009

  • Group gross margin improved 110 basis points year-on-year to 33.4% in the full year of 2009
  • Group gross margin decreased to 30.1% in the fourth quarter of 2009 from 32.7% in the fourth quarter 2008, driven by acute shortage and sharp increase in raw milk costs at the end of 2009
  • EBITDA margin increased to 14.1% in the full year of 2009 compared to 12.8% in 2008
  • On a constant currency basis (in rubles), EBITDA increased by 8.5% year-on-year in the full year of 2009
  • Group revenue in US dollars decreased 22.8% year-on-year to US$2,181.1 million in the full year of 2009, driven by ruble devaluation, and partially offset by improved sales mix in Dairy and stronger volumes in Beverages and Baby Food
  • Operating profit margin improved to 9.2% in the full year of 2009 from 8.7% in 2008
  • Net income in US dollars increased 14.6% year-on-year to US$116.5 million in the full year of 2009
  • On a constant currency basis (in rubles), net income increased by 46.4% year-on-year in the full year of 2009
  • As of the end of the full year of 2009, our net debt decreased by 30.5% year-on-year to US$275.3 million
  • Our free cash flow grew to US$187.0 million in the full year of 2009 from US$139.8 million in the same period of 2008

“Wimm-Bill-Dann achieved solid growth in profitability and significantly improved its balance sheet in 2009 despite continuing macroeconomic pressure and a temporary shortage of raw milk late in the year, which impacted dairy sales and margins in the fourth quarter,” said Tony Maher, Wimm-Bill-Dann’s Chief Executive Officer. “While we were forced to restrict the production of some of our dairy products in the fourth quarter, on the whole, we succeeded in further strengthening our market position. We increased our market share and maintained our leading market position in baby food. We accelerated share gains in beverages, enhancing our market position. Furthermore, and most importantly, we are confident in the fundamentals of all of our markets and remain fully committed to our strategy of profitable growth coupled with sound financial discipline.”

“Group revenue in US dollars decreased 22.8% year-on-year to US$2,181.1 million in the full year of 2009, and by 7% year-on-year to US$585.5 million in the fourth quarter of 2009, driven by ruble devaluation, and partially offset by improved sales mix in dairy and stronger volumes in beverages and baby food. Group revenue in rubles stood flat year-on-year in the fourth quarter of 2009.”

“For the full year of 2009, group gross margins increased 110 basis points year-over-year to 33.4%, reflecting improved gross margins in all business segments. In 2009, gross margin in beverages increased 60 basis points to 39.7%, dairy improved 30 basis points to 29.4%, and baby food continued its extraordinary performance, reaching 48.0%, up 110 basis points. Additionally, our EBITDA margin increased 130 basis points year-over-year to 14.1% in 2009, evidence of our efforts to drive efficiency gains and cost savings throughout the business.”

“Despite the new challenges we faced in 2009, we remain optimistic about the coming year. We made significant progress in the last year strengthening our operations, investing in our brands, expanding our market share, and strengthening our balance sheet,” Tony Maher added.

Key Financial Indicators for Full Year and 4Q 2009 vs. 2008

            FY 2009   FY 2008   Change   4Q 2009   4Q 2008   Change US$ ‘mln

US$ ‘mln

US$ ‘mln

US$ ‘mln

  Sales 2,181.1 2,823.6 (22.8%) 585.5 629.4 (7.0%) Dairy 1,530.2 2,095.9 (27.0%) 414.8 465.9 (11.0%) Beverages 406.6 473.2 (14.1%) 103.2 100.7 2.5% Baby Food 244.2 254.5 (4.0%) 67.4 62.8 7.4% Gross profit 728.3 913.0 (20.2%) 176.4 206.0 (14.4%) Gross margin, % 33.4% 32.3% 110 bp 30.1% 32.7% (260 bp) Selling and distribution expenses (379.7) (488.1) (22.2%) (107.4) (122.4) (12.3%) General and administrative expenses (137.4) (171.4) (19.8%) (40.3) (34.9) 15.4% Operating income 201.7 245.1 (17.7%) 24.6 51.5 (52.3%) Operating margin, % 9.2% 8.7% 50 bp 4.2% 8.2% (400 bp) Financial expenses, net (43.2) (101.5) (57.4%) (11.5) (65.0) (82.3%) Net income (loss) 116.5 101.7 14.6% 7.1 (7.9) 190.6% EBITDA 306.6 361.0 (15.1%) 60.0 78.2 (23.3%) EBITDA margin, %   14.1%   12.8%   130 bp   10.2%   12.4%   (220 bp) CAPEX excluding acquisitions   121.8   195.3   (37.6%)   45.0   36.4   23.6%

Dairy

Sales in US dollars in the Dairy Segment decreased 27.0% to US$1,530.2 million in the full year of 2009 from US$2,095.9 million in the same period of 2008. This was driven mainly by the negative exchange rate. The average dollar selling price declined 21.8% to US$1.11 per 1 kg in the full year of 2009 from US$1.42 per 1 kg in the same period last year. The gross margin in the Dairy Segment increased to 29.4% in the full year of 2009 from 29.1% in 2008, driven by improved sales mix. Due to a sharp increase in raw milk costs in late 2009, caused by an acute dry and raw milk shortage, the gross margin in the Dairy Segment fell to 24.9% in the fourth quarter of 2009 from 28.9% in the fourth quarter of 2008.

Beverages

Sales in US dollars decreased 14.1% to US$406.6 million in the full year of 2009 compared to US$473.2 million in the same period of 2008. This was driven by the negative exchange rate and partially offset by strong volume growth and pricing. The average dollar selling price decreased 17.5% to US$0.76 per liter in the full year of 2009 from US$0.93 per liter in the same period of 2008. The gross margin in the Beverage Segment increased to 39.7% in the full year of 2009 from 39.1% in 2008, due to improved efficiency and lower concentrate costs.

Baby Food

Sales in US dollars in the Baby Food Segment decreased 4.0% to US$244.2 million in the full year of 2009 from US$254.5 million in the same period of 2008, due to the negative exchange rate and partially offset by strong volume growth. The average dollar selling price decreased 20.6% to US$1.82 per kg in the full year of 2009 from US$2.29 per kg in 2008. The gross margin in the Baby Food Segment increased to 48.0% in the full year of 2009 from 46.9% in 2008.

Key Cost Elements

In the full year of 2009, selling and distribution expenses decreased 22.2% year-on-year to US$379.7 million. Sales and distribution expenses as a percentage of sales increased slightly by 10 basis points year-on-year to 17.4% in the full year of 2009, driven by advertising and marketing expenses, which increased, as a percentage of sales, to 6.4% in 2009 from 5.0% in 2008. General and administrative expenses decreased 19.8% year-on-year to US$137.4 million in the full year of 2009. General and administrative expenses, as a percentage of sales, increased by 20 basis points year-on-year to 6.3%.

Operating profit in US dollars decreased 17.7% year-on-year to US$201.7 million in the full year of 2009. Operating profit margin improved to 9.2% in the full year of 2009 from 8.7% in 2008.

EBITDA in US dollars declined 15.1% year-on-year to US$306.6 million. EBITDA margin improved to 14.1% in the full year of 2009 compared to 12.8% in 2008. On a constant currency basis (in rubles), EBITDA increased 8.5% year-on-year in the full year of 2009.

In the full year of 2009, financial expenses declined 57.4% to US$43.2 million compared to US$101.5 million in the same period of 2008. This was mainly due to a decrease in currency remeasurement loss. In the full year of 2009, currency remeasurement loss amounted to US$11.6 million compared to the loss of US$61.4 million in 2008. Currency remeasurement loss is a non cash item.

Our effective tax rate decreased to 25.7% in the full year of 2009 from 27.8% in 2008.

Net Income

Net income in US dollars increased 14.6% to US$116.5 million in the full year of 2009 from US$101.7 million in the full year of 2008. In the fourth quarter of 2009, net income in US dollars amounted to US$7.1 million compared to the net loss of US$7.9 million in the fourth quarter of 2008.

On a constant currency basis (in rubles), net income increased by 46.4% year-on-year in the full year of 2009, and grew almost 300% in the fourth quarter of 2009 year-on-year.

Debt and Cash Flows

As of the end of the full year of 2009, our net debt decreased by 30.5% year-on-year to US$275.3 million, and our net debt-to-EBITDA ratio declined to 0.9 as of the end of 2009 from 1.1 in 2008.

Operating cash flow for the full year of 2009 totaled $312.3 million compared to $321.2 million in 2008. Our free cash flow grew to US$187.0 million in the full year of 2009 from US$139.8 million in the same period of 2008.

 

Attachment A

Reconciliation of EBITDA and EBITDA margin to US GAAP Net Income

EBITDA is a non-U.S. GAAP financial measure. The following table presents reconciliation of EBITDA to net income (and EBITDA margin to net income as a percentage of sales), the most directly comparable U.S. GAAP financial measure.

       

12 months ended

12 months ended

December 31, 2009

December 31, 2008

US$ ‘mln

% of sales

US$ ‘mln

 

% of sales

  Net income 116.5 5.3% 101.7 3.6% Add: Depreciation and amortization 104.9 4.8% 115.8 4.1% Add: Income tax expense 40.7 2.0% 39.9 1.4% Add: Interest expense 33.5 1.5% 44.5 1.6% Less: Interest income (4.6) (0.2%) (6.6) (0.2%) Less: Currency remeasurement (gains)/losses, net 11.6 0.5% 61.4 2.2% Add: Bank charges 2.7 0.1% 2.9 0.1% Add: Noncontrolling interests 1.2 0.1% 2.0 0.1% Add: Other (gains)/losses 0.1 0.01% (0.6) (0.02%)   EBITDA 306.6 14.1% 361.0 12.8%  

EBITDA represents net income before interest, income taxes and depreciation and amortization, adjusted for interest income, currency remeasurement gains, bank charges and other financial expenses and noncontrolling interest. EBITDA margin is EBITDA expressed as a percentage of sales.

 

We present EBITDA because we consider it an important supplemental measure of our operating performance. In particular, we believe EBITDA provides useful information to securities analysts, investors and other interested parties because it is used in the “debt to EBITDA” debt incurrence financial measurement in certain of our financing arrangements.

 

EBITDA has limitations as an analytical tool, and you should not consider it in isolation, or as substitute for analysis of our operating results as reported under U.S. GAAP. Moreover, other companies in our industry may calculate EBITDA differently or may use it for different purposes than we do, limiting its usefulness as a comparative measure.

 

EBITDA also should not be considered as an alternative to cash flow from operating activities or as a measure of our liquidity. In particular, EBITDA should not be considered as a measure of discretionary cash available to us to invest in the growth of our business.

 

Consolidated Statements of Financial Position

(Amounts in thousands of U.S. dollars)

    December 31,

2009(unaudited)

 

2008(audited)

Assets Current assets: Cash and cash equivalents

$

248,521

$ 277,252 Trade receivables, net 112,083 125,453 Inventory 191,334 223,768 Taxes receivable 32,304 64,916 Advances paid 22,678 14,834 Deferred tax asset 15,159 11,828 Other current assets   19,381       15,699   Total current assets 641,460 733,750   Non-current assets: Property, plant and equipment, net 699,996 693,468 Intangible assets, net 38,688 34,999 Goodwill 105,643 108,748 Other non-current assets   3,017       6,000   Total non-current assets   847,344       843,215   Total assets $ 1,488,804     $ 1,576,965    

Consolidated Statements of Financial Position

(Amounts in thousands of U.S. dollars)

(continued)

  December 31,

2009(unaudited)

 

2008(audited)

Liabilities and equity Current liabilities: Trade accounts payable $

135,825

$ 133,886 Advances received 10,762 8,342 Short-term loans 4,521 66,278 Long-term loans, current portion 22,308 8,632 Long-term notes payable, current portion 185,835 159,153 Taxes payable 13,667 18,984 Accrued liabilities 54,969 33,864 Other payables   28,249       43,073   Total current liabilities 456,136 472,212   Long-term liabilities: Long-term loans 285,998 327,157 Long-term notes payable - 88,494 Other long-term payables 21,215 10,048 Deferred taxes – long-term portion   22,179       22,754   Total long-term liabilities   329,392       448,453   Total liabilities   785,528       920,665    

Equity

  Shareholders’ equity: Common stock: 44,000,000 shares authorized and issued with a par value of 20 Russian rubles; 41,846,022 shares outstanding as of December 31, 2009 and 43,725,535 shares outstanding as of December 31, 2008 29,908 29,908 Share premium account 163,781 164,132 Treasury stock, at cost (54,802 ) (3,014 ) Accumulated other comprehensive income (loss): Currency translation adjustment (32,167 ) (17,214 ) Retained earnings   587,160       470,625   Equity attributable to shareholders   693,880       644,437     Equity attributable to noncontrolling interests   9,396       11,863     Total equity   703,276       656,300         Total liabilities and equity $ 1,488,804     $ 1,576,965    

Consolidated Statements of Income

(Amounts in thousands of U.S. dollars, except share and per share data)

    Year ended December 31,

2009(unaudited)

 

2008(audited)

 

2007(audited)

    Sales $ 2,181,062 $ 2,823,564 $ 2,438,328   Cost of sales   (1,452,737 )     (1,910,528 )     (1,654,879 )   Gross profit 728,325 913,036 783,449   Selling and distribution expenses (379,659 ) (488,110 ) (387,853 ) General and administrative expenses (137,440 ) (171,400 ) (180,922 ) Other operating expenses, net   (9,552 )     (8,383 )     (704 )   Operating income 201,674 245,143 213,970   Financial income and expenses, net   (43,224 )     (101,504 )     (16,851 )   Income before provision for income taxes 158,450 143,639 197,119   Provision for income taxes (40,678 ) (39,898 ) (54,302 )             Consolidated net income $ 117,772     $ 103,741     $ 142,817    

Net income attributable to noncontrolling interests

  (1,237 )     (2,029 )     (2,769 )  

Net income attributable to WBD Foods shareholders

$ 116,535     $ 101,712     $ 140,048    

Net income per common share attributable to WBD Foods shareholders - basic and diluted

$ 2.73     $ 2.31     $ 3.18     Weighted average number of shares outstanding, basic and diluted 42,763,668 43,993,827 44,000,000  

Condensed Consolidated Statements of Cash Flows

(Amounts in thousands of U.S. dollars)

    Year ended December 31,

2009(unaudited)

 

2008(audited)

 

2007(audited)

Cash flows from operating activities:       Consolidated net income $ 117,772 $ 103,741 $ 142,817   Adjustments to reconcile net income to net cash provided by operating activities 117,955 183,941 71,720 Changes in operating assets and liabilities   76,569       33,508       (117,733 )   Total cash provided by operating activities $ 312,296     $ 321,190     $ 96,804     Cash flows from investing activities: Cash paid for property, plant and equipment (128,846 ) (189,003 ) (189,049 ) Proceeds from disposal of property, plant and equipment 2,683 6,454 3,668 Cash returned from short-term bank deposits and other current assets – – 6,800 Other investing activities   901       1,195       390   Net cash used in investing activities   (125,262 )     (181,354 )     (178,191 )   Cash flows from financing activities: Proceeds from long-term notes payable, net of debt issuance costs 95,814 207,473 147,909 Short-term loans and notes, net (56,312 ) (30,454 ) (33,946 ) Repayment of long-term loans and notes (160,724 ) (308,917 ) (5,081 ) Proceeds from long-term loans 7,233 315,579 6,778 Repayment of long-term payables (11,891 ) (14,445 ) (18,811 ) Cash paid for treasury stock acquisition (58,632 ) (3,014 ) – Dividends paid to noncontrolling interests (544 ) – (5,420 ) Cash paid for acquisition of subsidiaries, net of cash acquired   (2,280 )     (4,050 )     (24,850 ) Total cash provided by (used in) financing activities   (187,336 )     162,172       66,579     Impact of exchange rate differences on cash and cash equivalents   (28,429 )     (58,208 )     7,950     Net increase (decrease) in cash and cash equivalents (28,731 ) 243,800 (6,858 ) Cash and cash equivalents, at beginning of the year   277,252       33,452       40,310   Cash and cash equivalents, at the end of the year $ 248,521     $ 277,252     $ 33,452  

Some of the information contained in this press release may contain projections or other forward-looking statements regarding future events or the future financial performance of Wimm-Bill-Dann Foods OJSC, as defined in the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. We wish to caution you that these statements are only predictions and that actual events or results may differ materially. We do not intend to update these statements to conform them to actual results. We refer you to the documents Wimm-Bill-Dann Foods OJSC files from time to time with the U.S. Securities and Exchange Commission, specifically, the Company's most recent Form 20-F. These documents contain and identify important factors, including those contained in the section captioned "Risk Factors" in our Form 20-F, that could cause the actual results to differ materially from those contained in our projections or forward-looking statements, including, among others, potential fluctuations in quarterly results, and risks associated with our competitive environment, acquisition strategy, ability to develop new products or maintain market share, brand and company image, operating in Russia, volatility of stock price, financial risk management, and future growth.

NOTES TO EDITORS

Wimm-Bill-Dann Foods OJSC was founded in 1992 and is the largest manufacturer of dairy products and a leading producer of juices and beverages in Russia and the CIS. The company produces dairy products (main brands include: Domik v Derevne, Chudo, Imunele, Bio Max and more), juices (J7, Lubimy Sad, 100% Gold), Essentuki mineral water and Rodniki Rossii natural water, Zdraivery kids’ brand and Agusha baby food.

The company has 37 manufacturing facilities in Russia, Ukraine, Kyrgyzstan, Uzbekistan and Georgia with over 16,000 employees. In 2005, Wimm-Bill-Dann became the first Russian dairy producer to receive approval from the European Commission to export its products into the European Union.

In 2009, Standard & Poor's Governance Services confirmed WBD’s governance, accountability, management, metrics, and analysis (GAMMA) score “GAMMA- 7+”. The score reflects the effective work of the Board of Directors and, in particular, the real influence of independent directors in the decision-making process and the adherence of the controlling shareholders to the highest standards of corporate governance.

Wimm Bill Dann (NYSE:WBD)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Wimm Bill Dann Charts.
Wimm Bill Dann (NYSE:WBD)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Wimm Bill Dann Charts.